• Poster

Cost-effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naïve Adults With HIV-1 Infection in the United Kingdom

Citation

Wilkins, E., Fisher, M., Brogan, A. J., & Talbird, S. E. (2014, May). Cost-effectiveness Analysis of Tenofovir/Emtricitabine and Abacavir/Lamivudine in Combination With Efavirenz or Atazanavir/Ritonavir for Treatment-Naïve Adults With HIV-1 Infection in the United Kingdom. Presented at ISPOR 19th Annual International Meeting, .

Abstract